Funding
Seed · Biotech

Estrigenix Therapeutics raises $2m seed financing

Talents Fund I participated in financing for estrogen receptor-beta therapeutics.

Updated Oct 16, 2026By RoundOS Funding desk

Estrigenix Therapeutics raised $2 million in seed financing on July 21, with participation from Talents Fund I. The company develops selective estrogen receptor-beta therapeutics for women's health and neurodegenerative diseases.

Funding history

Seed · This round$2M

Sources

  1. Estrigenix Therapeuticsprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Cognitive Credit

Cognitive Credit provides corporate credit data, financial models and AI analysis tools for investment banks and asset managers.

$40MStrategic growth investment · Oct 22, 2026

Related